These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18627903)

  • 1. Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease.
    Leal A; Ichim TE; Marleau AM; Lara F; Kaushal S; Riordan NH
    Cell Immunol; 2008; 253(1-2):11-5. PubMed ID: 18627903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
    Jones BJ; McTaggart SJ
    Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease.
    McTaggart SJ; Atkinson K
    Nephrology (Carlton); 2007 Feb; 12(1):44-52. PubMed ID: 17295660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells.
    Giordano A; Galderisi U; Marino IR
    J Cell Physiol; 2007 Apr; 211(1):27-35. PubMed ID: 17226788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy in allogeneic hematopoietic stem cell transplantation--not just a case for effector cells.
    Troeger A; Meisel R; Moritz T; Dilloo D
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S59-64. PubMed ID: 15812533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats.
    Aksu AE; Horibe E; Sacks J; Ikeguchi R; Breitinger J; Scozio M; Unadkat J; Feili-Hariri M
    Clin Immunol; 2008 Jun; 127(3):348-58. PubMed ID: 18387852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells and inflammatory lung diseases.
    Iyer SS; Co C; Rojas M
    Panminerva Med; 2009 Mar; 51(1):5-16. PubMed ID: 19352305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
    Müller I; Kordowich S; Holzwarth C; Isensee G; Lang P; Neunhoeffer F; Dominici M; Greil J; Handgretinger R
    Blood Cells Mol Dis; 2008; 40(1):25-32. PubMed ID: 17869550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy.
    Hoogduijn MJ; Popp F; Verbeek R; Masoodi M; Nicolaou A; Baan C; Dahlke MH
    Int Immunopharmacol; 2010 Dec; 10(12):1496-500. PubMed ID: 20619384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
    Gonzalo-Daganzo R; Regidor C; Martín-Donaire T; Rico MA; Bautista G; Krsnik I; Forés R; Ojeda E; Sanjuán I; García-Marco JA; Navarro B; Gil S; Sánchez R; Panadero N; Gutiérrez Y; García-Berciano M; Pérez N; Millán I; Cabrera R; Fernández MN
    Cytotherapy; 2009; 11(3):278-88. PubMed ID: 19308773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological properties of mesenchymal stem cells and clinical implications.
    Patel SA; Sherman L; Munoz J; Rameshwar P
    Arch Immunol Ther Exp (Warsz); 2008; 56(1):1-8. PubMed ID: 18250975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation.
    Le Blanc K; Ringdén O
    Curr Opin Immunol; 2006 Oct; 18(5):586-91. PubMed ID: 16879957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MSC immune tolerance in cellular cardiomyoplasty.
    Chiu RC
    Semin Thorac Cardiovasc Surg; 2008; 20(2):115-8. PubMed ID: 18707643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium.
    von Bonin M; Stölzel F; Goedecke A; Richter K; Wuschek N; Hölig K; Platzbecker U; Illmer T; Schaich M; Schetelig J; Kiani A; Ordemann R; Ehninger G; Schmitz M; Bornhäuser M
    Bone Marrow Transplant; 2009 Feb; 43(3):245-51. PubMed ID: 18820709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
    Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for mesenchymal stem cells in the control of graft-versus-host disease.
    Cohen JL; Sudres M
    Transplantation; 2009 May; 87(9 Suppl):S53-4. PubMed ID: 19424007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation by mesenchymal stem cells and clinical experience.
    Le Blanc K; Ringdén O
    J Intern Med; 2007 Nov; 262(5):509-25. PubMed ID: 17949362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell therapy for degenerative inflammatory disorders.
    Müller I; Lymperi S; Dazzi F
    Curr Opin Organ Transplant; 2008 Dec; 13(6):639-44. PubMed ID: 19060556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cells.
    Bernardo ME; Locatelli F; Fibbe WE
    Ann N Y Acad Sci; 2009 Sep; 1176():101-17. PubMed ID: 19796238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell and gene therapy using mesenchymal stem cells (MSCs).
    Ozawa K; Sato K; Oh I; Ozaki K; Uchibori R; Obara Y; Kikuchi Y; Ito T; Okada T; Urabe M; Mizukami H; Kume A
    J Autoimmun; 2008 May; 30(3):121-7. PubMed ID: 18249090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.